✦ LIBER ✦

The risk of recurrent venous thromboembolism: The Austrian Study on Recurrent Venous Thromboembolism

✍ Scribed by Paul Alexander Kyrle; Sabine Eichinger

Publisher: Springer Vienna
Year: 2003
Tongue: English
Weight: 78 KB
Volume: 115
Category: Article
ISSN: 0043-5325
DOI: 10.1007/bf03041030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predicting the risk of venous thromboemb

Predicting the risk of venous thromboembolism recurrence

✍ John A. Heit 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 867 KB

## Abstract Venous thromboembolism (VTE) is a chronic disease with a 30% ten‐year recurrence rate. The highest incidence of recurrence is in the first 6 months. Active cancer significantly increases the hazard of early recurrence, and the proportions of time on standard heparin with an APTT ≥ 0.2 a

Impact and clinical significance of recu

Impact and clinical significance of recurrent venous thromboembolism

✍ Professor N. Labropoulos; G. Spentzouris; A. P. Gasparis; M. Meissner 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 2 views

FV Leiden mutation and risk of recurrent

FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population

✍ Mirjana Kovac; Danijela Mikovic; Nebojsa Antonijevic; Ljiljana Rakicevic; Valent 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 142 KB

Incidence of recurrent venous thromboemb

Incidence of recurrent venous thromboembolism of patients after termination of treatment with ximelagatran

✍ Job Harenberg; Ingrid Jörg; Christel Weiss 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 94 KB

Recent advances in the treatment of thro

Recent advances in the treatment of thromboembolic diseases: Venous thromboembolism

✍ Y.K. Agrawal; Hitesh Vaidya; Hardik Bhatt; Kuntal Manna; Pathik Brahmkshatriya 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB

## Abstract Venous thromboembolic diseases are the major concern of rising cost of healthcare and are commonest health problem across the globe. Both genetic and acquired risk factors are believed to be strongly linked with these diseases. Commonly encountered problems to the therapy include dose f

Home treatment of deep venous thrombosis

Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism

✍ Enric Grau; Jose M. Tenias; Esperanza Real; Jose Medrano; Rosario Ferrer; Emilio 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB 👁 2 views

## Abstract Outpatient treatment of deep venous thrombosis (DVT) with low molecular weight heparin (LMWH) seems as safe and effective as inpatient treatment with unfractionated heparin (UFH). However, most of the randomized trials comparing a LMWH with UFH described clinical outcomes within 3–6 mon